About Finecure Pharmaceuticals Limited
Data last updated:
Finecure Pharmaceuticals Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 18 March 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2005PLC045724. Its GSTIN is 24AAACF9157A1ZZ (Gujarat). The company holds 3 GST registrations, all of them active.
The company has an authorised share capital of ₹20 Cr and a paid-up capital of ₹12.71 Cr. It is led by directors including Vikash Rajgarhia (Managing Director) and Vivek Rajgarhia (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 1201 Mondeal Heights Nr. Wide Angle S.G. Highway, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹201.85 Cr, a decline of 9% compared to the previous year. For the same year it recorded a net loss of ₹9.9 Cr (net margin -4.9%) and EBITDA of ₹4.06 Cr (EBITDA margin 2%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 9% over five years.
The company has about 454 employees on its provident fund (EPFO) records. Its group structure includes 1 subsidiary.
The company is associated with 2 brands: Finecure Medical Equipment and Finecure pharma. As per MCA filings, the company has open charges of ₹65.19 Cr and satisfied charges of ₹26.58 Cr on record. Court records list 26 cases involving the company, including 14 filed by the company and 12 filed against it; 8 cases are pending. The company has 18 deals on record (16 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.06 Cr; the latest was in March 2022. Its 6 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 2 smaller; the largest is Cheryl Laboratories Pvt Ltd with revenue of ₹206.58 Cr. The company has 1 MSME Form 1 return on record for the period ending Sep 2019, listing 7 overdue payments to 7 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website finecurepharma.com.
Company details
Contact details
Finecure Pharmaceuticals Limited's registered office is in Ahmedabad, Gujarat. Its website is finecurepharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressA – 1201 Mondeal Heights Nr. Wide Angle S.G. Highway, Ahmedabad, Gujarat, India – 380015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Finecure Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Finecure Pharmaceuticals operates two associated brands: Finecure Medical Equipment and Finecure pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures pharmaceutical formulations for therapeutic segments including antibiotics and pain management. | fine-cure.com | |
| Manufacturer of pharmaceutical formulations for various therapeutic areas | finecurepharma.com |
Business activity
The main business activities of Finecure Pharmaceuticals are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Finecure Pharmaceuticals Limited, buy the company report.
Financials of Finecure Pharmaceuticals Limited
FY 2025 filings availableFinecure Pharmaceuticals Limited reported revenue of ₹201.85 Cr (down 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 9% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 9%. EBITDA fell 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.06 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹9.9 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2% | ||||
| Net Profit Margin | -4.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Finecure Pharmaceuticals Limited, buy the company report.
Board of directors of Finecure Pharmaceuticals Limited
Finecure Pharmaceuticals has 6 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vivek Rajgarhia | Whole-Time Director | 18 Mar 2005 | 21 Years 7 Months | Current |
| Vishal Haremurari Rajgarhia | Whole-Time Director | 18 Mar 2005 | 21 Years 7 Months | Current |
| Vikash Rajgarhia Also directs: Global Medisciences Limited, Finecure Foundation | Managing Director | 18 Mar 2005 | 21 Years 7 Months | Current |
| Niraj Kumar Harodia | Director | 28 Jan 2025 | 1 Years 9 Months | Current |
| Anshu Krishnakumar Agrawal | Director | 21 Dec 2017 | 8 Years 10 Months | Current |
| Mukesh Tarachand Agarwal Also directs: Kashish Tex Private Limited, Finebiotics Pharma Limited | Director | 21 Dec 2017 | 8 Years 10 Months | Current |
Peer comparison
Finecure Pharmaceuticals Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cheryl Laboratories Pvt Ltd | ₹206.58 Cr (FY 2025) | 14.0% | Mumbai, Maharashtra, India | |||
| Smilax Laboratories Limited | ₹206.57 Cr (FY 2025) | -25.0% | Hyderabad, Telangana, India | |||
| Radison Labs Private Limited | ₹202.11 Cr (FY 2025) | 43.0% | Hyderabad, Telangana, India | |||
| Topnotch Chemicals Pvt Ltd | ₹201.92 Cr (FY 2024) | -14.0% | Navi Mumbai, Maharashtra, India | |||
| Finecure Pharmaceuticals Limitedthis company | ₹201.85 Cr (FY 2025) | -₹9.9 Cr | -4.9% | -9.0% | 454 | Ahmedabad, Gujarat, India |
| Astral Steritech Private Limited | ₹201.59 Cr (FY 2022) | -36.0% | Vadodara, Gujarat, India | |||
| Synergia Life Sciences Private Limited | ₹201.39 Cr (FY 2024) | -22.0% | Wada, Maharashtra, India |
To see the full peer comparison of Finecure Pharmaceuticals Limited, buy the company report.
Auditor
Finecure Pharmaceuticals Limited is audited by SHAH & IYER for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SHAH & IYER | FY 2024 | 124443W |
Shareholding
The shareholding of Finecure Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Finecure Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 06 Sep 2023 | 100779622 | Others | ₹5.9 Cr | Open | |
| 24 Mar 2023 | 100694498 | Sidbi | ₹1.89 Cr | Open | |
| 04 Mar 2020 | 100332311 | Sidbi | ₹22.32 Cr | Open | |
| 23 Jul 2019 | 100281446 | Standard Chartered Bank | ₹35 Cr | Open | |
| 10 Jun 2014 | 10543255 | Others | ₹8.82 Lakh | Open |
To see the full charge records of Finecure Pharmaceuticals Limited, buy the company report.
Total charge records: 14 View all charges
Deals & funding
Finecure Pharmaceuticals Limited has 18 deals on record (16 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.06 Cr; the latest was in March 2022.
Deals on record (5 of 18)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Jan 2014 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: Global Medisciences Limited |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: Global Medisciences Limited , 3 individuals Seller: 3 individuals |
| Mar 2010 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Mihir Agencies Pvt Ltd |
| Mar 2009 | Secondary share transfer | Undisclosed | Buyer: Global Medisciences Limited Seller: an individual |
| Sep 2008 | Secondary share transfer | Undisclosed | Buyer: Global Medisciences Limited Seller: 3 individuals |
To see the full deal history of Finecure Pharmaceuticals Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Finecure Pharmaceuticals Limited has 26 court cases on record: 14 filed by Finecure Pharmaceuticals, 12 filed against it. 8 cases are pending and 18 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 14 | 5 | 2 |
| High courts | 12 | 7 | 6 |
Cases on record (5 of 26)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Delhi | Commercial suit | Filed by the company against Laborate Pharmaceuticals India Ltd & Anr. | Pending |
| High Court of Delhi | Commercial suit | Filed against the company by Sun Pharma Laboratories Ltd | Pending |
| High Court of Delhi | Court case (FAO(OS) (COMM)) | Filed against the company by Sun Pharma Laboratories Ltd. | Disposed |
| District court, East, Delhi | Commercial suit | Filed against the company by Gland Pharma Ltd. | Disposed |
| District court, Ahmedabad, Gujarat | Criminal complaint | Filed by the company against Calix Life Sciences Pvt Ltd and 2 others | Disposed |
To see the full case history of Finecure Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Finecure Pharmaceuticals Limited was last rated by Crisil on 26 Feb 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Crisil | 26 Feb 2021 |
To see the full credit ratings and regulatory alerts of Finecure Pharmaceuticals Limited, buy the company report.
MSME payment delays
Finecure Pharmaceuticals Limited has 1 MSME Form 1 return on record for the period ending Sep 2019, listing 7 overdue payments to 7 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 7)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Paramshakti Foils | |||
| Elnova Pharma | |||
| Spansules Pharmatech Private Limited | |||
| Stabicoat Vitamins | |||
| an individual supplier |
To see the full MSME payment records of Finecure Pharmaceuticals Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Finecure Pharmaceuticals has 1 subsidiary company and 1 associated company. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Finecure Foundation | U85300GJ2021NPL120309 |
To see the full group structure of Finecure Pharmaceuticals Limited, buy the company report.
Employees & EPFO
Finecure Pharmaceuticals Limited has a workforce of 454 employees on its EPFO records as of Mar 07, 2025, across 1 active EPFO establishment.
GST
Finecure Pharmaceuticals has 3 GST registrations: 3 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAACF9157A1ZZ | Gujarat | Active | 05 Sep 2017 |
| 05AAACF9157A1ZZ | Uttarakhand | Active | 01 Jul 2017 |
| 09AAACF9157A1ZR | Uttar Pradesh | Active | 14 Jul 2020 |
To see the full GST registrations and return filing status of Finecure Pharmaceuticals Limited, buy the company report.
Recent activity
Finecure Pharmaceuticals Limited has 12 board changes on record since 2005: 6 appointments and 6 cessations. The latest: Niraj Kumar Harodia was appointed as Director on 28 Jan 2025.
31 earlier events are in the company report.
Frequently asked questions
Finecure Pharmaceuticals is an active public limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 18 March 2005 (21+ years old) and is registered under CIN U24230GJ2005PLC045724.
Finecure Pharmaceuticals has 6 current directors:
- Vikash Rajgarhia - Managing Director
- Vivek Rajgarhia - Whole-Time Director
- Vishal Haremurari Rajgarhia - Whole-Time Director
- Niraj Kumar Harodia - Director
- Anshu Krishnakumar Agrawal - Director
- Mukesh Tarachand Agarwal - Director
The latest financial statements of Finecure Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Finecure Pharmaceuticals is 24AAACF9157A1ZZ, registered in Gujarat. The company has 3 GST registrations in all, of which 3 are active. Other active GSTINs include 05AAACF9157A1ZZ (Uttarakhand), 09AAACF9157A1ZR (Uttar Pradesh).
The CIN (Corporate Identification Number) of Finecure Pharmaceuticals is U24230GJ2005PLC045724. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Finecure Pharmaceuticals has 26 court cases on record: 14 filed by the company and 12 filed against it. 8 are pending. Most are in the district courts.
Finecure Pharmaceuticals was incorporated on 18 March 2005, making it 21+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Finecure Pharmaceuticals has 18 deals on record (16 secondary share transfers, 2 funding rounds), with disclosed funding of ₹1.06 Cr; the latest was in March 2022.
The peers of Finecure Pharmaceuticals by revenue are Cheryl Laboratories Pvt Ltd, Smilax Laboratories Limited, Radison Labs Private Limited, Topnotch Chemicals Pvt Ltd, Astral Steritech Private Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Niraj Kumar Harodia was appointed as Director on 28 Jan 2025. Parshva Shashikant Jhaveri ceased to be Director on 01 Nov 2024. Anjala Sultania ceased to be Director on 08 Dec 2020. Finecure Pharmaceuticals has 12 board changes on record in total.
Finecure Pharmaceuticals has 1 MSME Form 1 return on record for the period ending Sep 2019, listing 7 overdue payments to 7 micro and small suppliers. The latest return was filed on 27 Oct 2019.
Finecure Pharmaceuticals can be reached through the website finecurepharma.com. Its registered office is in Ahmedabad, Gujarat, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
